财报发布时间 - Cintas Corporation计划于2025年7月17日市场开盘前发布2025财年第四季度(截至2025年5月)财报 [1] 盈利预期 - 过去60天Zacks一致盈利预期保持稳定 - 公司过去四个季度均超出盈利预期 平均超出幅度达7.6% [1] - 当前季度调整后每股收益共识预期为1.07美元 同比增长7% [6] 业务板块表现 - 制服租赁与设施服务部门预计收入20.2亿美元 同比增长5.7% 主要来自新客户增长和现有客户产品渗透 [2] - 急救与安全服务部门预计收入3.131亿美元 同比增长12.8% 受AED租赁、洗眼站和WaterBreak产品需求推动 [3] 收购影响 - 2024年3月收购Paris Uniform Services增强公司在宾夕法尼亚、纽约、马里兰和西弗吉尼亚的市场地位 [4] - 2024年2月收购SITEX加强了美国中西部地区的市场地位 [4] 财务指标 - 预计营业收入将同比增长50个基点 受益于运营执行和定价策略 [5] - 预计总营收26.3亿美元 同比增长6.3% [6] - 销售成本及SG&A费用预计7.144亿美元 同比增长7% [7] 风险因素 - 美元走强可能损害海外业务表现 [7] 同业公司比较 - Equifax预计2025年第二季度盈利可能超出预期 过去四个季度平均超出4.2% [11] - PayPal预计2025年第二季度盈利可能超出预期 过去四个季度平均超出14% [12] - TransUnion预计2025年第二季度盈利可能超出预期 过去四个季度平均超出2.8% [12][13]

Investors might want to bet on Marex Group PLC (MRX) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Individua ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock characte ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even ...

ACNB (ACNB) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Individual investors often fi ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Whil ...

Investors might want to bet on Rapt Therapeutics (RAPT) , as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the sys ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock characte ...

Cellectar Biosciences, Inc. (CLRB) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Th ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock characte ...